Long form guides and explainers.

Blood sugar and vision: what changes first

Short term blur versus long term retina risk, explained in plain language.

Lutein and zeaxanthin: what the research actually suggests

Where evidence is strongest, where claims overreach, and what questions change the decision.

AREDS2 explained: who it is for (and who it is not)

What the evidence showed, what it did not, and why staging matters.

When light hurts: Stephanie’s second opinion

A fictional story about photophobia, premature reassurance, and what changes with a thorough second opinion.

Blue light myths: what matters and what does not

Separate sleep timing effects from eye health claims and focus on what drives comfort.

AI in eye care: what it can do today

How screening and triage work, where AI is strong, and what questions matter.

OCT explained: the scan that changed eye care

What OCT shows, why trends matter, and how it shapes modern monitoring.

Cataract surgery explained: lenses, tradeoffs, and timing

A neutral guide to lens options, night vision tradeoffs, and when “timing” becomes the real decision.

Glaucoma basics: the tests that actually matter

Pressure is only one piece. Here’s what monitoring tracks and why progression is the main concern.

LASIK and PRK: candidacy, risks, and realistic outcomes

What screening is trying to prevent, how to think about side effects, and what “good outcomes” really mean.

Retina injections in plain language

What injections target, why schedules matter, and how follow up decisions work.

Myopia control: what is proven vs popular

Outdoor time, near work, lenses and drops, and how to evaluate claims.

Dry eye routines: what they target and why they help

Why routines help when they match the driver and when evaluation is needed.

Gene therapy in eye care: promise and limits

Eligibility, realistic outcomes, and how to judge claims without hype.

Second opinions: a practical playbook

Records, framing questions, and comparing plans when decisions are high impact.